I have MS and had to have blood work before I can move forward with my new therapy. I tested positive for Tuberculosis. X-rays cleared me of active TB. I have latent TB and am being put on Isoniazid for 9 months along with B6. I’m still breastfeeding my 19 month old. Is there anything I need to watch for in him?
Announcement
Collapse
No announcement yet.
Welcome to our forum! Before posting your questions, please read the following terms:
- 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
- 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
- 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
- 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.
By posting to the forums, you acknowledge and agree to these terms.
The InfantRisk team
Latent TB
Collapse
X
-
Isoniazid (INH) is an antimicrobial agent primarily used to treat tuberculosis. Following doses of 5 and 10 mg/kg, one report measured peak milk levels at 6 mg/L and 9 mg/L respectively.[1] Isoniazid was not measurable in the infant's serum but was detected in the urine of several infants. In another study, following a maternal dose of 300 mg of isoniazid, the concentration of isoniazid in milk peaked at 3 hours at 16.6 mg/L while the acetyl derivative (AcINH) was 3.76 mg/L.[2] The 24 hour excretion of INH in milk was estimated at 7 mg. The authors felt this dose was potentially hazardous to a breastfed infant.
In a recent and well-done study in seven exclusively lactating women (at 33 days or steady state) who were receiving 300 mg isoniazid daily in a single dose (and rifampin and ethambutol) the mean (AUC) of isoniazid in plasma and milk was 18.4 µg/mL/24 hours and 14.4 µg/mL/24 hours respectively.[3] The mean milk/plasma ratio (AUC) was 0.89 and the calculated relative infant dose was 1.2%. In this nicely done study, peak levels are clearly evident at 1 hour and fall rapidly at 4 hours.
I'd suggest the mom avoid breastfeeding for 2-4 hours following administration of INH to avoid the peak plasma concentrations at 2 hours.
Observe infants for fatigue, weakness, anorexia, nausea, and vomiting in the breastfed infant (these are unlikely).
Tom Hale Ph.d.
Comment